Key result
Systemic sclerosis myocardium shows perforin-expressing killer cell infiltration and upregulated cardiomyocyte costimulatory molecules.
Why the study?
The mechanisms of heart failure in patients with progressive systemic sclerosis, particularly the role of cell-mediated cardiac myocyte injury, were not well understood.
Case Report (n=1)
No
Single-case finding in systemic sclerosis; leaves open whether perforin+ killer cells drive cardiac injury and needs validation before any clinical inference.
A 54-year-old woman with progressive systemic sclerosis (PSS) was admitted to hospital because of dyspnea and chest pain. Echocardiogram revealed diffuse hypokinesis of the left ventricle (ejection fraction 24%). Methylprednisolone, heparin, and diuretics were administered, without benefit. Anemia, thrombocytopenia, and renal dysfunction rapidly progressed, and she died of heart failure on the 14th hospital day. Immunohistochemical study of the myocardial tissue showed mild to moderate cell infiltration, mainly consisting of natural killer (NK) cells, macrophages, cytotoxic T lymphocytes (CTLs), and T helper cells. Perforin, a cytolytic factor, was expressed in the infiltrating CTLs and NK cells, indicating that these cells were activated killer cells. Furthermore, human leukocyte antigen classes I and II, intercellular adhesion molecule-1, as well as costimulatory molecules B7-1, B7-2, and CD40, all of which are known not to be expressed in cardiac myocytes under normal conditions, were moderately to strongly expressed in cardiac myocytes. There was no detectable level of enterovirus genomes in the polymerase chain reaction products from the myocardial tissue of this patient. These findings strongly suggest that the infiltrating killer cells recognized cardiac myocytes as target cells and directly damaged them by releasing perforin. Enhanced expression of these antigens may have played an important role in the activation and cytotoxicity of the infiltrating killer cells. Absence of enterovirus genomes in the myocardial tissue may suggest that this autoimmune process is primarily induced by PSS.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (1999) conducted a case report in Progressive systemic sclerosis (PSS) with heart failure (n=1). Progressive systemic sclerosis was evaluated on Myocardial tissue immunohistochemistry and enterovirus genome detection. Myocardial tissue from a patient with progressive systemic sclerosis showed infiltration of perforin-expressing killer cells and enhanced expression of costimulatory molecules on cardiac myocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: